Sarfaraz Ali - 09 Aug 2022 Form 4 Insider Report for Novo Integrated Sciences, Inc. (NVOS)

Role
Director
Signature
/s/ Sarfaraz Ali
Issuer symbol
NVOS
Transactions as of
09 Aug 2022
Net transactions value
$0
Form type
4
Filing time
10 Aug 2022, 13:01:17 UTC
Previous filing
10 Aug 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NVOS Stock Option (right to buy) Award $0 +39,480 $0.000000 39,480 09 Aug 2022 Common Stock 39,480 $1.90 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a grant, pursuant to the issuer's 2021 Equity Incentive Plan, approved by the issuer's Board of Directors. The stock option vests, and becomes exercisable, with respect to 3,290 shares each month, beginning on the date of grant, until August 9, 2023.